Morie Gertz, MD, on Clinical Trials and Controversies in Smoldering MM

By Blood Cancer Talks - May 19, 2023
In this episode of “Blood Cancer Talks,” the hosts discuss managing smoldering multiple myeloma (MM) and the controversies surrounding it with Dr. Gertz of the Mayo Clinic.
Dr. Gertz and the hosts provide listeners with an overview of risk-stratification approaches in smoldering MM, including the Mayo 2018 model, the PANGEA model, the PETHEMA model, and the International Myeloma Working Group model. They also discuss the current clinical trial landscape in smoldering MM and how Dr. Gertz approaches smoldering MM.
Advertisement
Advertisement
Advertisement
Editorial Board